NONALCOHOLIC FATTY LIVER
Clinical trials for NONALCOHOLIC FATTY LIVER explained in plain language.
Never miss a new study
Get alerted when new NONALCOHOLIC FATTY LIVER trials appear
Sign up with your email to follow new studies for NONALCOHOLIC FATTY LIVER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Blood donation may double as diabetes treatment, study suggests
Disease control CompletedThis study tested whether regularly donating blood to lower iron levels can improve blood sugar control and reduce fatty liver in people with prediabetes or diabetes. 132 adults aged 40-75 were assigned to either donate blood or a control group. Researchers measured changes in bl…
Matched conditions: NONALCOHOLIC FATTY LIVER
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 23, 2026 11:57 UTC
-
Fatty liver drug shows promise in small trial
Disease control CompletedThis pilot study tested a drug called ibutamoren in 12 adults with nonalcoholic fatty liver disease (NAFLD). The goal was to see if it could lower fat in the liver. Participants took the drug for 6 months, and researchers measured liver fat using special MRI scans. The study was …
Matched conditions: NONALCOHOLIC FATTY LIVER
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 22, 2026 12:04 UTC
-
Massive study tracks fatty liver disease patients to uncover Real-World treatment patterns
Knowledge-focused CompletedThis study followed over 7,300 people with nonalcoholic fatty liver disease (NAFLD) and its more severe form, NASH, in regular doctor visits. Researchers aimed to understand how the disease progresses and what treatments doctors are using, since no drugs are officially approved f…
Matched conditions: NONALCOHOLIC FATTY LIVER
Sponsor: Target PharmaSolutions, Inc. • Aim: Knowledge-focused
Last updated Jun 17, 2026 12:07 UTC